6092 — Enbio Holdings Income Statement
0.000.00%
Last trade - 00:00
- ¥5bn
- ¥10bn
- ¥8bn
- 36
- 64
- 25
- 33
2019 March 31st | 2020 March 31st | 2021 March 31st | 2022 March 31st | 2023 March 31st | |
---|---|---|---|---|---|
Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
Source: | Yuho | Yuho | Yuho | Yuho | Yuho |
Standards: | JAS | JAS | JAS | JAS | JAS |
Status: | Final | Final | Final | Final | Final |
Revenue | |||||
Total Revenue | 8,563 | 7,408 | 6,841 | 8,988 | 8,120 |
Cost of Revenue | |||||
Gross Profit | 1,978 | 2,088 | 1,890 | 2,426 | 2,764 |
Selling / General / Administrative Expenses | |||||
Research And Development | |||||
Unusual Expense / Income | |||||
Other Operating Expenses | |||||
Total Operating Expenses | 8,426 | 7,032 | 6,339 | 7,855 | 6,873 |
Operating Profit | 137 | 376 | 502 | 1,133 | 1,247 |
Gain / Loss on Sale of Assets | |||||
Total Net Non Operating Interest Income / Expense | |||||
Other Net Non Operating Costs | |||||
Net Income Before Taxes | -60.3 | 834 | 488 | 1,099 | 1,233 |
Provision for Income Taxes | |||||
Net Income After Taxes | -155 | 532 | 331 | 707 | 795 |
Minority Interest | |||||
Net Income Before Extraordinary Items | |||||
Net Income | -151 | 555 | 304 | 654 | 812 |
Adjustments to Net Income | |||||
Income Available to Common Shareholders Excluding Extraordinary Items | |||||
Income Available to Common Shareholders Including Extraordinary Items | |||||
Diluted Net Income | -151 | 555 | 304 | 654 | 812 |
Diluted Weighted Average Shares | |||||
Basic EPS Including Extraordinary Items | |||||
Diluted EPS Including Extraordinary Items | |||||
Diluted EPS Excluding Extraordinary Items | |||||
Normalised Income Before Taxes | |||||
Normalised Income After Taxes | |||||
Normalised Income Available to Common Shareholders | |||||
Diluted Normalised EPS | 29.1 | 54.8 | 57.6 | 109 | 134 |
Dividends per Share |